DPY19L2: A Potential Drug Target Or Biomarker for Neurological and Cancer-Related Disorders

Target Name: DPY19L2

NCBI ID: G283417

DPY19L2

DPY19L2: A Potential Drug Target Or Biomarker for Neurological and Cancer-Related Disorders

DPY19L2 (FLJ36166) is a protein that is expressed in various tissues of the body, including the brain, pancreas, and muscle. It is a member of the dynein family of proteins, which are involved in the transport of organelles, such as mitochondria and endoplasmic reticulum, to the cytoplasm.

One of the unique features of DPY19L2 is its ability to interact with the protein known as TDP-450, which is a nuclear protein that is involved in the regulation of mitochondrial function. This interaction betweenDPY19L2 and TDP-450 suggests thatDPY19L2 may be a drug target or biomarker for diseases that are characterized by dysfunction in mitochondrial function, such as Alzheimer's disease, Parkinson's disease, and certain forms of cancer.

In addition to its potential role as a drug target or biomarker, DPY19L2 is also of interest as a potential therapeutic agent for the treatment of certain neurological disorders. For example, studies have suggested thatDPY19L2 may be involved in the development and progression of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. By targetingDPY19L2 with drugs that can modulate its activity, researchers may be able to develop new treatments for these debilitating conditions.

DPY19L2 is also of interest as a potential biomarker for certain types of cancer. For example, studies have suggested thatDPY19L2 may be expressed in the brains of individuals with certain types of cancer, such as neuroblastoma and ovarian cancer. By detecting the expression ofDPY19L2 in these cells, researchers may be able to develop new diagnostic tests for cancer, as well as potential targets for cancer therapy.

In conclusion, DPY19L2 is a protein that is expressed in various tissues of the body, and it is of interest as a potential drug target or biomarker for a variety of neurological and cancer-related disorders. Further research is needed to fully understand the role ofDPY19L2 in these conditions, and to determine its potential as a therapeutic agent.

Protein Name: Dpy-19 Like 2

Functions: Probable C-mannosyltransferase that mediates C-mannosylation of tryptophan residues on target proteins

The "DPY19L2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about DPY19L2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets